{"id":66065,"name":"QUOIN PHARMACEUTICALS, INC.","slug":"quoin-pharmaceuticals-inc","state":"VA","country":"United States of America","description":"Development and commercialization of therapeutic drug products that treat rare diseases.","totalSpending":60000,"filings":5,"yearlySpending":[{"year":2025,"income":60000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"PHA","display":"Pharmacy"}],"firms":["FORWARD GLOBAL"],"lobbyists":["LEAH CHARETTE","AVA COFIELL","NOE GARCIA"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating ","Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating ","Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating ","Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating ","Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating "]}